Table 4.
Results of multivariate analysis of SARS-CoV-2 neutralizing antibodies by logistic regression model.
| Item | Regression Coefficient | Standard Error | Wald x2 | p Value | OR | 95% CI |
|---|---|---|---|---|---|---|
| Sex | −0.764 | 0.621 | 1.513 | 0.219 | 0.466 | (0.138, 1.573) |
| Age | −0.029 | 0.021 | 1.946 | 0.163 | 0.972 | (0.933, 1.012) |
| Height | 0.045 | 0.046 | 0.966 | 0.326 | 1.046 | (0.956, 1.144) |
| Weight | 0.005 | 0.025 | 0.040 | 0.842 | 1.005 | (0.957, 1.055) |
| Vaccine manufacturers | 0.463 | 0.435 | 1.136 | 0.287 | 1.589 | (0.678, 3.727) |
| Time of vaccination completed (weeks) | −0.109 | 0.032 | 11.569 | 0.001 | 0.897 | (0.842, 0.955) |
127 participants who had completed COVID-19 vaccination (inactivated SARS-CoV-2 vaccine, 64; CoronaVac, 61; CanSino, 2).